# Trade Mark Journal No.2025/051 19 December 2025

## WO0000001889677 (42)

Office of origin: European Union Intellectual Property Office (EUIPO)

Date of International Registration:29 August 2025
Date of designation in the UK: 29 August 2025

International priority date claimed: 29 April 2025 (European Union Intellectual Property Office (EUIPO)) (019179607)

Class 42
  Research and development services in the field of pharmaceuticals and drug discovery; development of processes and methods for medical and veterinary purposes; development of preparations for medical and veterinary purposes; scientific research for medical purposes, namely, screening for the identification of drug candidates; development of precision RNA therapeutics; development of tailored RNA-based corrective interventions to target the root causes of serious diseases; research and development of new medical products for others; development and identification of novel druggable sites for pharmacological intervention using a bioinformatic discovery platform in a wet lab; screening services, bioinformatics services and modelling services to harness natural processes and modulate gene expression through platforms to generate optimized small molecules, antisense oligonucleotides (ASOs) and small interfering RNAs (siRNAs); designing and developing algorithms and thermodynamic models.

Contera Pharma A/S

Representative: DE FRIES & TUFEKOVIC IP APS, Bredgade 30, DK-1260 Copenhagen K, DENMARK